Materials Healthcare Sector

LexaGene Holdings

Market Cap: CA$14.8m

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.

Resonance Health

Market Cap: AU$17.0m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa.

Ekso Bionics Holdings

Market Cap: US$10.9m

Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

SeaStar Medical Holding

Market Cap: US$10.8m

A commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

Pacific Health Care Organization

Market Cap: US$10.8m

Operates as a workers’ compensation cost containment company in the United States.

HeraMED

Market Cap: AU$16.6m

A medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.

Athira Pharma

Market Cap: US$10.6m

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

Pharmala Biotech Holdings

Market Cap: CA$14.8m

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

SOL Global Investments

Market Cap: CA$14.7m

A private equity firm specializing in growth capital to small and mid-sized businesses.

BLIS Technologies

Market Cap: NZ$17.9m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

ReNerve

Market Cap: AU$16.4m

A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

Minerva Neurosciences

Market Cap: US$10.5m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Hemostemix

Market Cap: CA$14.5m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

CareView Communications

Market Cap: US$10.4m

Operates as a video monitoring solutions provider in the United States.

Kairos Pharma

Market Cap: US$10.4m

A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.

Telescope Innovations

Market Cap: CA$14.5m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Co-Diagnostics

Market Cap: US$10.3m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Hemogenyx Pharmaceuticals

Market Cap: UK£7.7m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood cancer.

Aprea Therapeutics

Market Cap: US$10.2m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Firebrick Pharma

Market Cap: AU$15.9m

Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.

Rafarma Pharmaceuticals

Market Cap: US$10.2m

A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.

Dogwood Therapeutics

Market Cap: US$10.2m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Fusion Antibodies

Market Cap: UK£7.6m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

KRTL Holding Group

Market Cap: US$10.1m

KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.

HCW Biologics

Market Cap: US$10.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

Immuron

Market Cap: AU$15.4m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Pharma-Bio Serv

Market Cap: US$9.9m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Kiora Pharmaceuticals

Market Cap: US$9.8m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

RUA Life Sciences

Market Cap: UK£7.4m

Engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally.

Cyclerion Therapeutics

Market Cap: US$9.8m

A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.

Guided Therapeutics

Market Cap: US$9.7m

A medical technology company, develops medical devices.

Oxford BioDynamics

Market Cap: UK£7.3m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

Inhibitor Therapeutics

Market Cap: US$9.7m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

Predictive Oncology

Market Cap: US$9.6m

A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies.

Chimeric Therapeutics

Market Cap: AU$14.8m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

Universal Biosensors

Market Cap: AU$14.6m

Through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally.